Why Doctors Can't Actually Prescribe Your Innovation: The 68% Roadblock
The bottleneck in women's health is no longer clinical willingness - it is administrative gatekeeping.
Boston MA -- October 27: New therapeutics and maternal-fetal diagnostics are being developed faster than payer utilization management protocols can adapt.
The Women's Health Infrastructure Report 2026 exposes a critical cross-sector disconnect between frontline clinical readiness and archaic insurance infrastructure.
This structural disconnect represents just one of the critical commercial gaps uncovered through the Women's Health Infrastructure Report 2026, a cross-sector study bringing together perspectives from health plans, providers, employers, clinicians, life sciences organisations and innovators.
The full report features detailed findings, expert commentary, benchmark data and practical implications for healthcare leaders looking to understand where women's health is heading next.
Women’s HealthX 2026 | From Rhetoric to Results
Encore Boston Harbor | December 3-4 2026
Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems. Join the region's foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.